Last Updated: 06/05/2026

Astellas Engineered Small Molecules U.K.

Cambridge

Mitochondrial disease drug discovery subsidiary of Astellas Pharma

Astellas Engineered Small Molecules U.K. is a Cambridge-based drug discovery subsidiary of Astellas Pharma, operating as part of the company's Mitobridge Division alongside its US counterpart Mitobridge Inc.

Originally founded as Nanna Therapeutics and acquired by Astellas in 2020, the entity applies a proprietary high-throughput screening platform based on DNA-encoded chemical libraries and microfluidics technology to discover novel small molecule therapeutics.

Research focuses on mitochondrial biology, autophagy, mitophagy, ageing and immunometabolism.

Biotech Drug Discovery AI & Machine Learning

Ageing & Longevity Toxicology Small Molecule Drugs

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

Previously Known As

Nanna Therapeutics, Bactevo

Member of

One Nucleus BioIndustry Association

Similar Companies

MeOmics Precision Medicine

Cardiff